This means that passive immunization with tau antibodies is really a practical therapeutic concentrate on and that the CSF degree of p-tau262/356 or with the microtubule binding area (MTBD) can function a practical biomarker of tau pathology to monitor tau therapeutics in clinical trials.During this assay, scientists add extracts from Alzheimer’s